Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
- PMID: 12228717
- DOI: 10.1126/science.1073514
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
Abstract
Antigen-presenting cells (APCs) can induce tolerance or immunity. We describe a subset of human APCs that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation in vitro. IDO-positive APCs constituted a discrete subset identified by coexpression of the cell-surface markers CD123 and CCR6. In the dendritic cell (DC) lineage, IDO-mediated suppressor activity was present in fully mature as well as immature CD123+ DCs. IDO+ DCs could also be readily detected in vivo, which suggests that these cells may represent a regulatory subset of APCs in humans.
Similar articles
-
Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?Transplantation. 2007 Feb 27;83(4):468-73. doi: 10.1097/01.tp.0000251646.09702.ec. Transplantation. 2007. PMID: 17318080
-
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.Int Immunol. 2004 Oct;16(10):1391-401. doi: 10.1093/intimm/dxh140. Epub 2004 Sep 6. Int Immunol. 2004. PMID: 15351783
-
Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?Blood. 2005 Mar 15;105(6):2480-6. doi: 10.1182/blood-2004-06-2103. Epub 2004 Nov 30. Blood. 2005. PMID: 15572592
-
Indoleamine 2,3-dioxygenase in transplantation.Nephrology (Carlton). 2008 Jun;13(3):204-11. doi: 10.1111/j.1440-1797.2007.00921.x. Epub 2008 Jan 23. Nephrology (Carlton). 2008. PMID: 18221253 Review.
-
Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Eur J Immunol. 2012 Aug;42(8):1932-7. doi: 10.1002/eji.201242572. Eur J Immunol. 2012. PMID: 22865044 Review.
Cited by
-
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29. Nat Immunol. 2012. PMID: 22842346 Free PMC article.
-
The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth.EPMA J. 2010 Mar;1(1):46-55. doi: 10.1007/s13167-010-0009-2. Epub 2010 Mar 19. EPMA J. 2010. PMID: 23199040 Free PMC article.
-
The Protective Effect of IDO1 Inhibition in Aβ-Treated Neurons and APP/PS1 Mice.Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231214861. doi: 10.1177/15333175231214861. Am J Alzheimers Dis Other Demen. 2023. PMID: 37944012 Free PMC article.
-
Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.Front Immunol. 2012 May 11;3:109. doi: 10.3389/fimmu.2012.00109. eCollection 2012. Front Immunol. 2012. PMID: 22593757 Free PMC article.
-
Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer.Front Immunol. 2024 Jan 25;14:1225175. doi: 10.3389/fimmu.2023.1225175. eCollection 2023. Front Immunol. 2024. PMID: 38332913 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous